Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 22Neoplasms 16Leukemia, Myeloid, Acute 10Ovarian Neoplasms 7Neoplasm Metastasis 7Lung Neoplasms 7Lymphoma 6Hematologic Neoplasms 6Colorectal Neoplasms 6Prostatic Neoplasms 5Multiple Myeloma 5Glioblastoma 5Stomach Neoplasms 4Leukemia 4Fatigue 4Carcinoma, Non-Small-Cell Lung 4Vulvar Neoplasms 3Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Triple Negative Breast Neoplasms 3Sarcoma 3Pancreatic Neoplasms 3Pain 3Myelodysplastic Syndromes 3Motor Activity 3Melanoma 3Depression 3Anxiety Disorders 3Vaginal Neoplasms 2Rectal Neoplasms 2

Interventions

Exercise 6Transcranial Direct Current Stimulation 4Walking 3Memantine 3Tablets 2Standard of Care 2Methods 2Donepezil 2Cognitive Behavioral Therapy 2mazdutide 1lithium sulfate 1lime 1fasudil 1enzalutamide 1blueberry extract 1beta Carotene 1acetaminophen, aspirin, caffeine drug combination 1XENP 1595 1Vitamin E 1Vitamin D 1Ultraviolet Therapy 1Transcranial Magnetic Stimulation 1Time 1Therapeutics 1Tai Ji 1Sugars 1Sodium Chloride 1Sirolimus 1Silymarin 1Riluzole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Cognitive Dysfunction × Palliative Care × Clear all
NCT04669301 2025-07-15

Memory and Attention Adaptation Training-Geriatrics (MAAT-G) Phase II

University of Rochester

Phase NA Completed
72 enrolled 15 charts

Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡